Research programme: nitric oxide synthase type II inhibitors - Bayer HealthCare Pharmaceuticals/Pharmacopeia Drug Discovery

Drug Profile

Research programme: nitric oxide synthase type II inhibitors - Bayer HealthCare Pharmaceuticals/Pharmacopeia Drug Discovery

Alternative Names: Inducible nitric oxide synthase inhibitors - Bayer HealthCare Pharmaceuticals/Pharmacopeia; iNOS inhibitors - Bayer HealthCare Pharmaceuticals/Pharmacopeia; PS 891169; Research programme: inducible nitric oxide synthase inhibitors - Bayer HealthCare Pharmaceuticals/Pharmacopeia

Latest Information Update: 11 Jul 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pharmacopeia Drug Discovery
  • Developer Bayer HealthCare Pharmaceuticals; Pharmacopeia
  • Class Small molecules
  • Mechanism of Action Nitric oxide synthase type II inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Inflammation; Rheumatoid arthritis

Most Recent Events

  • 11 Jul 2007 Discontinued - Preclinical for Inflammation in USA (unspecified route)
  • 11 Jul 2007 Discontinued - Preclinical for Rheumatoid arthritis in USA (unspecified route)
  • 04 Apr 2007 Berlex Inc has been acquired by Bayer HealthCare
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top